Role of <i>Lactobacillus reuteri</i> in Human Health and Diseases.
Mu Q, Tavella VJ, Luo XM. · 2018
Read Role of <i>Lactobacillus reuteri</i> in Human Health and Diseases. by Mu Q, Tavella VJ, Luo XM. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5917019.txt.
Introduction
Mu and co-authors review Lactobacillus reuteri in human health and disease. Their review appeared in Frontiers in Microbiology. This probiotic bacterium lives in gut, skin, and breast milk. Its levels vary widely between people. It makes acids and reuterin that kill harmful microbes. That helps it reshape gut communities.
The bacterium can calm pro-inflammatory signals, they report. It supports regulatory T cells and strengthens the gut barrier. Fewer gut leaks may mean less body-wide inflammation. Its decline in recent decades tracks rising inflammatory disease. Adding it back may prevent or treat such illness. Readers get the evidence and the open questions.
Catalog record
| CREATOR | Mu Q, Tavella VJ, Luo XM. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 102 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Role of Lactobacillus reuteri in Human Health and Diseases By Qinghui Mu, Vincent J. Tavella, Xin M. Luo Published in: Frontiers in Microbiology DOI: 10.3389/fmicb.2018.00757 ABSTRACT Lactobacillus reuteri (L. reuteri) is a well-studied probiotic bacterium that can colonize a large number of mammals. In humans, L. reuteri is found in different body sites, including the gastrointestinal tract, urinary tract, skin, and breast milk. The abundance of L. reuteri varies among different individuals. Several beneficial effects of L. reuteri have been noted. First, L. reuteri can produce antimicrobial molecules, such as organic acids, ethanol, and reuterin. Due to its antimicrobial activity, L. reuteri is able to inhibit the colonization of pathogenic microbes and remodel the commensal microbiota composition in the host. Second, L. reuteri can benefit the host immune system. For instance, some L. reuteri strains can reduce the production of pro-inflammatory cytokines while promoting regulatory T cell development and function. Third, bearing the ability to strengthen the intestinal barrier, the colonization of L. reuteri may decrease the microbial translocation from the gut lumen to the tissues. Microbial translocation across the intestinal epithelium has been hypothesized as an initiator of inflammation. Therefore, inflammatory diseases, including those located in the gut as well as in remote tissues, may be ameliorated by increasing the colonization of L. reuteri. Notably, the decrease in the abundance of L. reuteri in humans in the past decades is correlated with an increase in the incidences of inflammatory diseases over the same period of time. Direct supplementation or prebiotic modulation of L. reuteri may be an attractive preventive and/or therapeutic avenue against inflammatory diseases. INTRODUCTION Probiotics are defined as “live microorganisms which, when administered in adequate amounts, confer a health benefit on the host” by the World Health Organization. While the idea to use probiotics for health benefits is not new, the interest has significantly increased in recent years (Islam, 2016). This may be due, in part, to the increase in antibiotic resistance particularly in the treatment of diseases in the gastrointestinal (GI) system, as well as an increasing desire by the public for natural health promotants. Those probiotic microorganisms that have been shown to have beneficial properties include Lactobacillus spp., Bifidobacterium spp., Saccharomyces boulardii, Propionibacterium spp., Streptococcus spp., Bacillus spp., Enterococcus spp., and some specific strains of Escherichia coli (Kechagia et al., 2013). There are certain criteria that a probiotic must have to be considered efficacious. These include the capacity to survive in the GI tract, a high resistance to gastric acids, the lack of any transferable antibiotic resistance genes, and the capacity to exert clear benefits in the host (Montalban-Arques et al., 2015). Probiotics promote a healthy body through diverse mechanisms. A widespread generalization describing common mechanisms among studied probiotic genera includes colonizing resistance, producing acid, and short chain fatty acid (SCFA), regulating intestinal transit, normalizing perturbed microbiota, increasing enterocyte turnover, and competitive exclusion of pathogens (Hill et al., 2014). Though not widely observed, there are a lot of effects among specific probiotic species, some being strain specific. For instance, some probiotic strains can improve host food digestion by metabolizing bile salt or complementing the functions of missing digestive enzymes (Amara and Shibl, 2015; Shi et al., 2016). Lactobacillus spp. are one of the most widely used probiotics and can be found in a large variety of food products throughout the world (Giraffa et al., 2010). The genus Lactobacillus comprises a large heterogeneous group of Gram-positive, nonsporulating, facultative anaerobic bacteria which include L. acidophilus, L. rhamnosus, L. bulgaricus, L. casei, and L. reuteri. This genus plays a very important role in food fermentation and can also be found in the GI system of humans and animals in variable amounts depending on the species, age of the host, or location within the gut (Duar et al., 2017). Animal studies and preclinical results have shown that Lactobacilli may help in the prevention and treatment of numerous GI tract disorders. Among these disorders are enteric infections, antibiotic-associated diarrhea, necrotizing enterocolitis in preterm neonates, inflammatory bowel disease, colorectal cancer, and irritable bowel syndrome (Lebeer et al., 2008). Although the GI tract is the site where Lactobacilli are believed to show the most benefits, probiotic applications of some Lactobacillus strains at other sites of the body have been reported. These include the prevention and treatment of urogenital diseases and bacterial vaginosis in women, atopic disease, food hypersensitivity, and the prevention of dental caries (Lebeer et al., 2008). One species of Lactobacillus, L. reuteri has multiple beneficial effects on host health such as prevention and/or amelioration of diverse disorders. L. reuteri was first isolated in 1962. It has been characterized as heterofermentative species that grows in oxygen-limited atmospheres and colonizes the GI tract of humans and animals (Kandler et al., 1980). The fact that it normally colonizes the GI tract may be the reason it confers great probiotic properties. This organism can withstand a wide variety of pH environments, employs multiple mechanisms that allow it to successfully inhibit pathogenic microorganisms, and has been shown to secrete antimicrobial intermediaries (Jacobsen et al., 1999; Valeur et al., 2004). L. reuteri has been shown to be one of the truly indigenous bacteria of the human GI tract (Sinkiewicz, 2010). It naturally colonizes a wide range of vertebrates, including pigs, rodents, and chickens. In fact, it has gone through long-term evolution to diversify into host-adapted lineages (Oh et al., 2010; Walter et al., 2011). This organism is most typically found in the proximal digestive tract of the host (Frese et al., 2013). Several studies have assessed the safety of this organism in adults, children, infants, and even in an HIV-infected population (Wolf et al., 1998; Valeur et al., 2004; Weizman and Alsheikh, 2006; Mangalat et al., 2012; Jones et al., 2012a,c; Hoy-Schulz et al., 2016). The results showed that a dose as high as 2.9 × 109 colony-forming units (cfu)/day was still well tolerated, safe, and efficacious in humans. There have also been numerous articles enumerating the benefits of L. reuteri as a probiotic. These benefits include promoting health, reducing infections, improving feed tolerance, enhancing the absorption of nutrients, minerals, and vitamins, modulating host immune responses, promoting gut mucosal integrity, and reducing bacterial translocation (Tubelius et al., 2005; McFall-Ngai, 2007; Indrio et al., 2008; Spinler et al., 2008; Hou et al., 2015). In the current review, we will focus on the particular probiotic, L. reuteri, and discuss its beneficial functions in promoting health and preventing infections and diverse diseases. PROBIOTIC PROPERTIES OF L. REUTERI There are some prerequisites for becoming potential probiotics: to survive in low pH and enzyme-enriched environments, to adhere to epithelium for host-probiotic interaction, competition with pathogenic microorganisms, and most importantly, safety. L. reuteri meets all of these requirements. Here, additional probiotic properties of L. reuteri are discussed that contribute to its diverse beneficial effects on host health and disease prevention and/or amelioration (Figure 1). [Figure: Probiotic properties of L. reuteri.] Gut Colonization of L. reuteri Built for digestion and absorption, some sites of the GI system have developed to be harsh for microorganism colonization. Examples of this can be seen in the low pH conditions caused by gastric acids and bile salts in upper small intestine. Thus, the very first step of